Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Thrombotic Thrombocytopenic Purpura | Case report

Cytomegalovirus induced refractory TTP in an immunocompetent individual: a case report

Authors: Medhini Boteju, Praveen Weeratunga, Ahalyaa Sivashangar, Thashi Chang

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Thrombotic thrombocytopenic purpura (TTP) is a rare, potentially fatal disease with multisystem involvement. Cytomegalovirus (CMV) infection as a cause of refractory TTP, has been reported only in immunocompromised individuals. We report a case of CMV-induced refractory TTP in an immunocompetent individual.

Case presentation

A 35-year-old, previously healthy Sri Lankan man, presented with fever for 3 days with gum bleeding and progressive drowsiness. His Glasgow coma scale score was 10/15. He did not have papilloedema or neck stiffness. Laboratory evaluation showed a severe thrombocytopenia with microangiopathic haemolytic anaemia. There was marginal renal impairment and normal coagulation profile. Non-contrast CT scan of brain was normal. A diagnosis of thrombotic thrombocytopenic purpura was made. Despite daily plasma exchanges and high-dose steroids, he failed to achieve the expected therapeutic response, thus demonstrating refractory TTP. On exploring for possible causes of refractoriness to treatment, a clinically significant PCR titre of CMV was detected. Treatment of CMV infection lead to complete recovery of TTP. His disease course was further complicated with spontaneous spinal haemorrhage leading to neurological sequelae.

Discussion and conclusions

This is the first report of CMV induced refractory TTP in an immunocompetent adult. It is also the first report of clinically significant spontaneous spinal haematoma in TTP. These two rare occurrences should be considered when patients with refractory TTP do not improve as expected.
Literature
1.
go back to reference Hovinga JAK. Thrombotic thrombocytopenic purpura: diagnostic criteria. Clinical features, and long term outcomes from 1995 through 2015. Blood adv. 2017(1):590. Hovinga JAK. Thrombotic thrombocytopenic purpura: diagnostic criteria. Clinical features, and long term outcomes from 1995 through 2015. Blood adv. 2017(1):590.
2.
go back to reference Pernat MA, Buturovic-Ponikvar J, Kovac J, et al. Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura. Ther Apher Dial. 2009;13(4):318–21.CrossRef Pernat MA, Buturovic-Ponikvar J, Kovac J, et al. Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura. Ther Apher Dial. 2009;13(4):318–21.CrossRef
3.
go back to reference Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325(6):398–403.CrossRef Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325(6):398–403.CrossRef
4.
go back to reference Cserti C, Landaw S, Uhl L. Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? Clin Apher. 2007;22:21.CrossRef Cserti C, Landaw S, Uhl L. Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? Clin Apher. 2007;22:21.CrossRef
5.
go back to reference Esteve V, Reynaga E, Et A. Cytomegalovirus infection-associated thrombotic microangiopathy as the first clinical manifestation of HIV primary infection. Nefrologia. 2006;26:639–41.PubMed Esteve V, Reynaga E, Et A. Cytomegalovirus infection-associated thrombotic microangiopathy as the first clinical manifestation of HIV primary infection. Nefrologia. 2006;26:639–41.PubMed
6.
go back to reference Ramasubbu K. Mullick thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis. 2003;5:98–103.CrossRef Ramasubbu K. Mullick thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis. 2003;5:98–103.CrossRef
7.
go back to reference Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation. 1998;65:1645–8.CrossRef Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation. 1998;65:1645–8.CrossRef
8.
go back to reference Froissart A, Buffet M, Veyradier A, et al. Efficacy and safety of first line rituximab in severe acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French thrombotic microangiopathies reference Centre. Crit Care Med. 2012;40:104.CrossRef Froissart A, Buffet M, Veyradier A, et al. Efficacy and safety of first line rituximab in severe acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French thrombotic microangiopathies reference Centre. Crit Care Med. 2012;40:104.CrossRef
9.
go back to reference Creager AJ, Brecher ME, Bandarenko N. Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion. 1998;38:419.CrossRef Creager AJ, Brecher ME, Bandarenko N. Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion. 1998;38:419.CrossRef
10.
go back to reference Kano Y, Shiohara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci. 2000;22(pg):196–204.CrossRef Kano Y, Shiohara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci. 2000;22(pg):196–204.CrossRef
11.
go back to reference Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients, Clin Infect Dis, 1997, vol. 24 (pg. 52-56).CrossRef Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients, Clin Infect Dis, 1997, vol. 24 (pg. 52-56).CrossRef
12.
go back to reference Maneerat Y, Wilairatana P, Pongpouratu E, et al. Herpes simplex virus type. 2, cytomegalovirus and Epstein-Barr virus infection in acute non. A to E hepatitis in Thai patients, Asian Pac J Allergy Immunol, 1997, vol. 15 (pg. 147–151). Maneerat Y, Wilairatana P, Pongpouratu E, et al. Herpes simplex virus type. 2, cytomegalovirus and Epstein-Barr virus infection in acute non. A to E hepatitis in Thai patients, Asian Pac J Allergy Immunol, 1997, vol. 15 (pg. 147–151).
13.
go back to reference Kunno A, Abe M, Yamada M, Murakami K. Clinical and histologic features of cytomegalovirus hepatitis in previously healthy adults, Liver, 1997, vol. 17 (pg. 129–132). Kunno A, Abe M, Yamada M, Murakami K. Clinical and histologic features of cytomegalovirus hepatitis in previously healthy adults, Liver, 1997, vol. 17 (pg. 129–132).
14.
go back to reference Studahl M, Ricksten A, Sandberg T, Bergstrom T, Elowson S. Cytomegalovirus encephalitis in four immunocompetent patients, Lancet, 1992, vol. 340 (pg. 1045-1046).CrossRef Studahl M, Ricksten A, Sandberg T, Bergstrom T, Elowson S. Cytomegalovirus encephalitis in four immunocompetent patients, Lancet, 1992, vol. 340 (pg. 1045-1046).CrossRef
15.
go back to reference Patra S, Samal SC, Chacko A, Mathan VI, Mathan MM. Cytomegalovirus infection of the human gastrointestinal tract, J Gastroenterol Hepatol , 1999, vol. 14 (pg. 973-976).CrossRef Patra S, Samal SC, Chacko A, Mathan VI, Mathan MM. Cytomegalovirus infection of the human gastrointestinal tract, J Gastroenterol Hepatol , 1999, vol. 14 (pg. 973-976).CrossRef
16.
go back to reference Ng FH, Chau TN, Cheung TC, et al. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci. 1999;44(pg):945–52.CrossRef Ng FH, Chau TN, Cheung TC, et al. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci. 1999;44(pg):945–52.CrossRef
17.
go back to reference Walter EA, Greenberg PD, Gilbert MJ. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333(16):1038–44.CrossRef Walter EA, Greenberg PD, Gilbert MJ. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333(16):1038–44.CrossRef
18.
go back to reference Silva RLD. Viral-associated thrombotic microangiopathies. Hematol Oncol Stem Cell Ther. 2011;4(2):51–9.CrossRef Silva RLD. Viral-associated thrombotic microangiopathies. Hematol Oncol Stem Cell Ther. 2011;4(2):51–9.CrossRef
19.
go back to reference Kwaan HC. Clinicopathologic features of thrombotic thrombocytopenicpurpura. Semin Hematol. l987;2:71–81. Kwaan HC. Clinicopathologic features of thrombotic thrombocytopenicpurpura. Semin Hematol. l987;2:71–81.
20.
go back to reference Gruber O, Wittig L, et al. Thrombotic thrombocytopenic purpura: MRI demonstration of persistent small cerebral infarcts after clinical recovery. Neuroradiology. 2000;42(8):616–8.CrossRef Gruber O, Wittig L, et al. Thrombotic thrombocytopenic purpura: MRI demonstration of persistent small cerebral infarcts after clinical recovery. Neuroradiology. 2000;42(8):616–8.CrossRef
21.
go back to reference Alungal J, Abdulla MC, et al. Multiple hemorrhagic infarcts in thrombotic thrombocytopenic purpura. Neuroimage: 2014 Vol : 62 (5) (Pg.582-583).CrossRef Alungal J, Abdulla MC, et al. Multiple hemorrhagic infarcts in thrombotic thrombocytopenic purpura. Neuroimage: 2014 Vol : 62 (5) (Pg.582-583).CrossRef
22.
go back to reference Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology. 1999;52(6):1285.CrossRef Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology. 1999;52(6):1285.CrossRef
Metadata
Title
Cytomegalovirus induced refractory TTP in an immunocompetent individual: a case report
Authors
Medhini Boteju
Praveen Weeratunga
Ahalyaa Sivashangar
Thashi Chang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4037-9

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue